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Reactive oxygen species (ROS) are considered an important factor in ischemia/reperfusion injury to cardiac myocites. Mitochondrial
respiration is an important source of ROS generation and hence a potential contributor to cardiac reperfusion injury. Appropriate treatment strategy
could be particularly useful to limit this ROS generation and associated mitochondrial dysfunction. In the present study, we examined the effect of
lowering the oxygen tension, at the onset of the reperfusion, on various parameters of mitochondrial bioenergetics in rat heart tissue. After
isolation of mitochondria from control, ischemic, normoxic and hypoxic reperfused rat heart, various bioenergetic parameters were evaluated such
as rates of mitochondrial oxygen consumption, complex I and complex III activity, H2O2 production and in addition, the degree of lipid
peroxidation, cardiolipin content and cardiolipin oxidation. We found that normoxic reperfusion significantly altered all these mitochondrial
parameters, while hypoxic reperfusion had a protective effect attenuating these alterations. This effect appears to be due, at least in part, to a
reduction of mitochondrial ROS generation with subsequent preservation of cardiolipin integrity, protection of mitochondrial function and
improvement of post-ischemic hemodynamic function of the heart.
© 2005 Elsevier B.V. All rights reserved.Keywords: Mitochondrial respiration; Complexes I and III activity; ROS generation; Cardiolipin oxidation; Rat heart hypoxic reperfusion1. Introduction
A large body of experimental evidences indicate that reactive
oxygen species (ROS) play an important role in producing lethal
cell injury associated with cardiac ischemia/reperfusion [1–6]. The
mechanism for the enhanced ROS generation and cellular and
subcellular target of ROS attack are not well established.
Mitochondria are considered an important locus of ROS pro-
duction mainly at the level of complexes I and III [7–10] of the
respiratory chain and hence a potential contributor to heart reper-
fusion injury. As a major source of ROS production, mitochon-
dria could be major targets of ROS attack. Given that ROS are⁎ Corresponding author. Tel.: +39 080 5443324; fax: +39 080 5443317.
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doi:10.1016/j.bbabio.2005.10.003highly reactive and short lived species, their effect should be
greatest in immediate area surrounding their locus of production.
It is conceivable that mitochondrial membrane constituents,
including the complexes of the respiratory chain and phospho-
lipid constituents, could be the major target of ROS attack.
Cardiolipin, a phospholipid of unusual structure localized
almost exclusively within the mitochondrial inner membrane, is
particularly rich in unsaturated fatty acids. Thus, mitochondrial
cardiolipin molecules are a possible and early target of ROS
attack, either because of their high content of unsaturated fatty
acids or because of their location in the inner mitochondrial
membrane near to the site of ROS production, mainly at the
level of complexes I and III of the respiratory chain [9,10]. This
phospholipid plays an important role in mitochondrial bio-
energetics, optimizing the activity of the respiratory chain
complexes [11–13].
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that the activity of the complexes I, III and IVof the respiratory
chain is reduced in mitochondria from ischemic/reperfused rat
heart [14–18]. This decrease has been ascribed to ROS-induced
cardiolipin oxidation. The impairment of mitochondrial com-
plexes I, III, IVactivity due to ROS-induced cardiolipin damage
may increase the electron leak from the electron transport chain
generating more superoxide anion radical and perpetuating a
cycle of oxygen–radical-induced damage, which ultimately
leads to a decrease in oxidative phosphorylation and to heart
failure on reperfusion.
It has been reported that the production of free radicals
occurs during the first minutes after cardiac reperfusion
[4,5,19]. Using electron magnetic resonance Zweier et al.
identified a spectral peak in heart compatible with an oxygen-
centred free radical which peaked during the first 10 s of the
reperfusion [4]. Thus, the first few minutes of reperfusion
constitute a critical phase as here lethal tissue injury, in addition
to that already developed during ischemia, may be initiated;
therefore modifications of the early phase of reperfusion
conditions may represent an opportunity of cardioprotection.
Appropriate treatment strategies could be particularly useful to
limit ROS production and ROS-induced alterations to mito-
chondrial structure and function and hence to protect ischemic
reperfused myocardium. Free radical scavengers have been
shown to attenuate reperfusion injury following ischemia
reperfusion [19]. As an alternative treatment to antioxidants, it
s conceivable that post-ischemic reperfusion injury could be
attenuated by oxygen tension control [20,21].
The present study examined the hypothesis that the
alterations to mitochondrial oxidative metabolism associated
to ischemia/reperfusion may be limited by lowering the oxygen
tension during reperfusion. We studied the effect of lowering the
pO2 during the first minutes of heart reperfusion on various
mitochondrial bioenergetic parameters such as oxygen con-
sumption, respiratory complexes activity, mitochondrial ROS
production rates, as well as on mitochondrial lipid peroxidation,
cardiolipin content and cardiolipin oxidation. In addition, since
ROS and mitochondrial damage play a role in contractility
dysfunction associated with reperfusion of ischemic heart, we
also tested the efficacy of lowering pO2 to limit the impairment
of ventricular mechanics in a reperfused heart model.
2. Materials and methods
2.1. Animal experiments
Animals received care in compliance with the “Principles of Laboratory
Animal Care” formulated by the National Society for Medical Research and the
“Guide for the Care and Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources and published by the National Institutes of Health
(NIH PublicationNo. 86-23, revised 1985), as well as with Italian laws on animal
experimentation. A model of isolated and perfused heart was used according to
Langendorff technique. Male Wistar rats weighing 250–300 g. were heparinized
and anesthetized with Thiopental 35 mg i.p. given. Heart were excised and
perfused at 37 °C under 10 ml·min−1 constant flow. Krebs–Henseleit solution
was used as perfusion buffer, saturated with O2/CO2 (95/5) gas mixture. pO2 was
monitored by an oxygen electrode (Instech Dual Oxygen, Plymouth Meeting,
PA) and maintained at a pO2 level of 600 mm Hg, which is considered normal inLangendorff preparations, due to the lack of haemoglobin [22]. In a second
reservoir Krebs–Henseleit solution had not been bubbled at all with the O2/CO2
mixture in order to maintain the solution at the atmospheric pO2 level of 150 mm
Hg, which is considered hypoxic for this model [22]. pH of the solutions was
maintained between 7.35 and 7.45 by adding 1N HCl if required.
Left ventricular (LV) isovolumic pressure was recorded by a strain-gauge
pressure transducer (Hewlett-Packard Medical Electronic Division, Model
1280C, Waltham, MA). The end-diastolic pressure (LVEDp) was adjusted to 5–
10 mm Hg. Aortic root pressure (RAp) was also monitored by a strain-gauge
pressure transducer (Hewlett-Packard Medical Electronic Division, Model
1280C, Waltham, MA), via a side-arm of the cannula. Pacing electrodes were
attached to atrial appendages and the heart was paced at 300 beats/min.
Control hearts were perfused for 60 min. Ischemic hearts were perfused for
15 min and then subjected to global ischemia for 30 min by turning off the
perfusion system. Normoxic reperfused hearts were reperfused for 15 min with a
Krebs–Henseleit solution oxygen buffered at the same pO2 level as before
ischemia (normoxic group: pO2 600 mm Hg). In the hypoxic reperfused group
of hearts the second reservoir containing Krebs–Henseleit solution, in which the
O2/CO2 mixture had not been bubbled at all, was connected to the perfusion
system during the first 3 min of reperfusion (hypoxic group: pO2 150 mm Hg).
In this hypoxic group, at the end of the 3rd min after starting reperfusion, the
perfusion system was connected again with the solution buffered at a pO2 of 600
mm Hg until the end of reperfusion (Fig. 1). Throughout each protocol,
including global ischemia, the temperature of the hearts was maintained at 37 °C
by a water-jacketed chamber. Left ventricular pressure curves were recorded just
before ischemia, and at the 1st, 2nd, 3rd, 4th, 5th, 10th, 15th min of reperfusion.
The following parameters were measured: left ventricular end-diastolic pressure
(LVEDp, mm Hg); systolic pressure (LVSp, mm Hg); developed pressure
(LVDp=LVSp−LVEDp, mm Hg); dP/dt (expressed as percent change of the
pre-ischemia value); root aortic pressure (RAp, mm Hg).
2.2. Isolation of mitochondria
Rat heart mitochondria were isolated in a medium of 250 mM sucrose, 10
mM Tris–HCl, 1 mM EGTA, pH 7.4, by differential centrifugation of heart
homogenates essentially as described previously [17]. Mitochondria were
resuspended in 250 mM sucrose, 10 mM Tris–HCl (pH 7.4) and stored in ice.
The yield of mitochondrial proteins (mg/g heart wet wt.) within each group of
animals was consistent, suggesting minimal variation in the preparations of the
mitochondrial fraction.
Mitochondrial protein concentration was measured by the biuret method
using serum albumin as standard.
2.3. Determination of mitochondrial H2O2 production
The rate of mitochondrial hydrogen peroxide production was estimated by
measuring the linear fluorescence increase induced by H2O2 oxidation of
dichlorofluorescin to the fluorescent dichlorofluorescein in the presence of
horseradish peroxidase [23]. Rat heart mitochondria (0.3 mg protein) were
suspended in 2.5 ml of a medium of 100 mM sucrose, 100 mM KCl, 5 mM Tris,
pH 7.4, supplemented with 7.5 μg horseradish peroxidase and 1 μM
dichlorofluorescein. The production of hydrogen peroxide was induced by
addition of 5 mMmalate+2 mM pyruvate or 5 mM succinate as substrates (state
4). The amount of H2O2 produced was calculated by measuring the fluorescence
changes upon addition of known amounts of H2O2.
2.4. Mitochondrial oxygen consumption
Mitochondrial ADP-dependent state 3 respiration was measured polaro-
graphically with an oxygen electrode at 25 °C. Respiration was initiated by the
addition of 2 mM pyruvate+5 mM malate or 5 mM succinate. After 2 min state
3 respiration was induced by the addition of 0.5 mM ADP.
2.5. Complex I activity
Complex I (NADH-CoQ reductase) activity was measured in mitochondrial
particles prepared by sonicating, under nitrogen atmosphere, 1 mg of rat heart
Fig. 1. Experimental protocol of ischemia and reperfusion in four groups of Langendorff rat heart preparations. Group C (control): hearts perfused for 60 min.
Group I (ischemic): hearts perfused for 15 min followed by 30 min global ischemia. Group N (normoxic): after 30 min of ischemia hearts were reperfused for
15 min at 600 mm Hg pO2. Group H (hypoxic): after 30 min ischemia hearts were reperfused at 150 mm Hg pO2 in the first 3 min and at 600 mm Hg pO2
afterwards.
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mixture contained 3 mM sodium azide, 1.2 μM antimycin A, 50 μM
decylubiquinone and 50 mM phosphate buffer pH 7.2. The mitochondrial
sample (50 μg) was added to 3 ml of the assay mixture and the reaction was
started by the addition of 60 μM NADH. The reaction was measured by
following the decrease in absorbance of NADH at 340 nm with a diode array
spectrophotometer. The activity was calculated using an extinction-coefficient
of 6.22 mM−1×cm−1 for NADH. The specific activity of the enzyme is
expressed as nmol of NADH oxidized/min/mg of mitochondrial protein. The
rotenone insensitive rate of NADH oxidation was measured and subtracted.
2.6. Complex III activity
The complex III activity (decylubiquinol/ferricytochrome c oxidoreductase)
was measured in mitochondrial particles prepared by sonicating 1 mg of rat heart
mitochondria dissolved in 1 ml of 50 mM phosphate buffer pH 7.2. The assay
mixture contained 3 mM sodium azide, 1.5 μM rotenone, 50 μM ferricyto-
chrome c and 50 mM phosphate buffer pH 7.2. The sample (10 μg) was added to
3 ml of the assay mixture and the reaction was started by the addition of 30 μM
of decylubiquinol. The reaction was measured with a diode array spectropho-
tometer by following the increase in reduced cytochrome c absorbance at
550–540 nm. The activity was calculated using an extinction-coefficient of 19.1
mM−1×cm−1.
The specific activity of the enzyme is expressed as nmol of cytochrome c
reduced/min/mg of mitochondrial particles.
Decylubiquinol was synthesized by reduction of decylubiqionone (10 μM)
with NaBH4 in 2 ml of 1:1 ethanol/H2O mixture (v/v, pH 2). The ubiquinol
formed was extracted twice with 1 mm of diethylether/isooctane 2:1 (v/v). The
combined organic phases were washed with 2 ml of 2 M NaCl and evaporated to
dryness at room temperature under a stream of nitrogen. The residue was
dissolved in ethanol and the resulting light yellow solution was acidified with
10 μl of 0.1 M HCl and stored at −20 °C.
2.7. Analysis of cardiolipin in mitochondrial membranes
Cardiolipin was analyzed by high-pressure liquid chromatography (HPLC)
using a Hewlett Packard series 1100 gradient liquid chromatograph. Lipids from
heart mitochondria were extracted with chloroform/methanol by the procedure
of Bligh and Dyer [24]. Lipid extraction was carried out on ice immediate afterthe preparation of mitochondria in the presence of BHT and under nitrogen
atmosphere. Phospholipids were separated by the HPLC method previously
described [25] with an Lichrosorb Si60 column (4.6×250 mm). The
chromatographic system was programmed for gradient elution using two
mobile phases: solvent A, hexane/2-propanol (6:8, v/v) and solvent B, hexane/
2-propanol/water (6:8:1.4, v/v/v). The percentage of solvent B in solvent Awas
increased in 15 min from 0% to 100%. Flow rate was 1 ml/min and detection at
206 nm. The peak of cardiolipin was identified by comparison with the retention
time of standard cardiolipin and rechromatographed by TLC.
2.8. Lipid and cardiolipin peroxidation
Lipid peroxidation was estimated by the appearance of conjugated dienes
as follows. Lipids were extracted from mitochondria by the Bligh e Dyer
procedure [24]. Lipid extracts from 4 mg of mitochondrial membrane were
dissolved in 2.5 ml of chloroform/methanol (1:1) and the absorption spectra
were followed between 210 and 310 nm [26] with a Perkin-Elmer Lambda 3B
spectrophotometer.
Peroxidized cardiolipin was identified by normal-phase HPLC, as described
above, with UV detection at 235 nm, indicative of conjugated dienes [26,27].
The resulting peak was rechromatographed by TLC and used as standard.
2.9. Statistical analysis
Measures of ventricular function have been expressed as mean values±S.E.
Statistical significance of the comparison between the time courses of values
obtained in hypoxic and normoxic group was calculated by two-way ANOVA
for repeated measures. All other results have been expressed as mean±S.E. and
their statistical significance was determined by the Student's t test.3. Results
Lipid peroxidation has been proposed to be a major
mechanism of ROS attack. This process is accompanied by
a rearrangement of unsaturated fatty acids double bonds,
leading to the formation of conjugated dienes which absorb
at 233 nm. Thus, the degree of mitochondrial membranes
Table 1
Respiratory activities in mitochondria isolated from control, ischemic, normoxic
and hypoxic reperfused rat heart






State 3 192±9.6 151±5.5⁎ 103±4.4⁎ 132±5.5⁎⁎
State 4 46±3.2 42±2.5 35±1.3⁎ 39±1.4
RCR 4.2±0.2 3.6±0. 25⁎ 2.9±0.12⁎ 3.4±0.11⁎⁎
Succinate
State 3 172±14.2 136±11.5⁎ 85±3.7⁎ 120±11.4⁎⁎
State 4 50±4.2 48±3.4 37±2.8⁎ 45±2.7⁎⁎
RCR 3.4±0.26 2.8±0.21⁎ 2.3±0.12⁎ 2.7±0.11⁎⁎
Mitochondrial respiratory activities were measured as described in Materials
and methods. Each value represents the mean±S.E. of eight separate
experiments.
⁎ Pb0.01 vs. control.
⁎⁎ Pb0.05 vs. normoxic reperfused.
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increase in absorbance of extracted membrane lipids at 233
nm. Fig. 2 shows absorbance values obtained from mito-
chondrial lipid extracts of control, ischemic, normoxic
reperfused and hypoxic reperfused rat heart. Mitochondria
from ischemic heart exhibited a 25% and those from
normoxic reperfused heart a 44% increase in the level of
lipid peroxidation, compared to the control heart. Hypoxic
reperfusion had a protective effect reducing the level of lipid
peroxidation.
Respiratory activities of mitochondria isolated from control,
ischemic, normoxic and hypoxic reperfused rat heart, measured
in the presence of pyruvate+malate or succinate as substrates
and ADP to stimulate respiration (state 3) are reported in Table
1. The rate of state 3 respiration was markedly decreased in
mitochondria isolated from normoxic reperfused rat heart, while
hypoxic reperfusion attenuated this decrease. Almost similar
results were obtained with succinate as substrate. State 4 rates of
respiration were slightly decreased in all these preparations of
mitochondria. The respiratory control ratio (RCR), an index of
mitochondrial membrane integrity, was also decreased in
mitochondria from reperfused rat heart, while low PO2
reperfusion limited this decrease.
Complex I and complex III activities were measured in all
these preparations of mitochondria. As shown in Fig. 3,
mitochondria from normoxic reperfused rat heart exhibited a
marked decrease in the activity of both these enzyme
complexes, compared with the control heart. Hypoxic
reperfusion had significant protective effect and actually
attenuated the decline in the complex I and complex III
activity.
It has been shown that addition of the respiratory substrates
pyruvate+malate or succinate to aerobic mitochondria results inFig. 2. Absorbance values of the conjugated dienes of mitochondrial lipids
extracted from control, ischemic, normoxic and hypoxic reperfused rat heart.
The conjugated dienes spectra were recorded as described in Materials and
methods. Each value represents the mean±S.E. of eight separate experiments.
*Pb0.05 vs. control; **Pb0.05 vs. normoxic reperfused.a generation of H2O2 which arises from superoxide anion
formed mainly at the level of complexes I and III [7,28,16]. The
capacity of mitochondria isolated from control, ischemic,Fig. 3. Complex I and complex III activity in mitochondria isolated from control,
ischemic, normoxic and hypoxic reperfused rat heart. Complex I (a) and
complex III (b) activities were measured as described in Materials and methods.
Each value represents the mean±S.E. of eight separate experiments. *Pb0.01
vs. control; **Pb0.05 vs. normoxic reperfused.
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generate oxygen radical in the presence of pyruvate+malate
or succinate was evaluated. The basal rate of H2O2 production
was significantly enhanced in mitochondria from normoxic
reperfused rat heart, respiring with pyruvate+malate or
succinate (Fig. 4). Under hypoxic reperfusion this H2O2
production was markedly decreased. We also measured the
rate of mitochondrial ROS production during the early phase
(2 min) of normoxic and hypoxic reperfusion. As shown in Fig.
4, at 2 min of normoxic reperfusion, the rate of mitochondrialFig. 4. H2O2 production in mitochondria isolated from control, ischemic,
normoxic and hypoxic reperfused rat heart. Mitochondria were isolated from
control, ischemic, and from normoxic and hypoxic reperfused hearts at 2 or 15
min of reperfusion. The H2O2 formation was induced by the addition of 2 mM
pyruvate+5 mM malate (a) or 5 mM succinate (b) and measured as described in
Materials and methods. Each value represents the mean±S.E. of eight
experiments or four experiments for 2 min reperfusion. *Pb0.01 vs. control;
**Pb0.05 vs. normoxic 15 min reperfused; ***Pb0.05 vs. normoxic 2 min
reperfused.
Fig. 5. Cardiolipin content in mitochondria isolated from control, ischemic,
normoxic and hypoxic reperfused rat heart. Mitochondrial cardiolipin content
was determined by the HPLC technique as described in Materials and
methods. Each value represents the mean±S.E. obtained from eight different
experiments. *Pb0.01 vs. control; **Pb0.05 vs. normoxic reperfused.ROS production was greatly enhanced. This early ROS
production was abolished under hypoxic condition, suggesting
that the protective effect of hypoxia occurs during the early
phase of reperfusion.
We have previously shown that mitochondrial cardiolipin
loss is mainly responsible for the defect in complex I and
complex III activity associated to heart reperfusion [16,17].
The effect of hypoxic reperfusion on mitochondrial cardioli-
pin content was tested. The content of mitochondrial
cardiolipin was measured by a very sensitive HPLC technique
set up in our laboratory with a detection limit of 0.5 nmol/Fig. 6. Relative content of peroxidized cardiolipin in mitochondria from control,
ischemic, normoxic and hypoxic reperfused rat heart. Mitochondrial content of
peroxidized cardiolipin was determined by the HPLC technique described in
Materials and methods. The content of peroxidized cardiolipin is expressed as
peak area (at 235 nm) per mg of phospholipids and the peak area of the control is
assumed as unit. Each value represents the mean±S.E. obtained from eight
different experiments. *Pb0.05 vs. control; **Pbb0.05 vs. normoxic
reperfused.
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reduced by 28% in mitochondria from ischemic heart and by
50% and 36% in mitochondria from normoxic and hypoxic
reperfused rat heart, respectively, compared to the control
heart.
We also measured the content of peroxidized cardiolipin in
these preparations of mitochondria. The content of peroxidized
cardiolipin was measured by an HPLC method based on the
absorbance at 233 nm, indicative of the formation of conjugated
dienes. As shown in Fig. 6, the content of peroxidized
cardiolipin was enhanced by 25%, 46% and 33% in
mitochondria isolated from ischemic, normoxic reperfused
and hypoxic reperfused rat hearts, respectively, compared to
control heart.
The effect of hypoxic reperfusion on the left ventricular
function was studied and the time course of LVEDp and
LVDp in these two groups of hearts is shown in Fig. 7. An
increase in LVEDp occurs during reperfusion which was
lesser in hypoxic than normoxic group of hearts, at the 15th
min the values being 62.3±5.8 vs. 86.9±4.8 mm Hg,
respectively. After reperfusion LVDp was lower than before
ischemia with a better recovery in hypoxic than in normoxic
group (40.6±3.7 vs. 15.0±1.3 mm Hg). It is worth noting
that differences between normoxic and hypoxic hearts are
clearly evident since the first minutes of reperfusion (see
Fig. 7), when the burst of ROS production occurs.Fig. 7. Changes in left ventricle end-diastolic pressure (LVEDp) and left
ventricle developed pressure (LVDp=systolic minus end-diastolic pressure), in
two groups of isolated and perfused rat hearts during 30 min ischemia and 15
min reperfusion. Closed circles: hearts reperfused at 600 mmHg pO2 for 15 min.
Open circles: hearts reperfused at 150 mm Hg pO2 during the first 3 min
followed by 12 min reperfusion at 600 mm Hg pO2 (see Fig. 1). Data are
expressed as mean values±S.E. Statistical significance calculated by two-way
ANOVA for repeated measures.4. Discussion
Reperfusion is a pre-requisite to salvaging viable myocar-
dium following an acute episode of ischemia. Reperfusion of
ischemic myocardium may paradoxically present some risk in
that can result in myocyte death, a phenomenon termed
reperfusion-injury. It is generally acknowledged that ische-
mic–reperfusion injury to cardiac myocytes is mediated, among
other factors, by an overproduction of oxygen free radicals.
These oxygen radicals can be generated by several mechanisms
including the xanthine oxidase reaction [29–31], the activity of
NADPH oxidase [32] and mitochondrial respiration [33,34].
Because of the abundance of mitochondria in cardiac
myocytes, mitochondrial electron transport chain might be an
important subcellular source of ROS and hence a potential
contributor to heart reperfusion injury. Mitochondria consume
N90% of the oxygen used by the cell, and the mitochondrial
respiratory chain generates a continuous flux of oxygen
radicals. It has been estimated that around 2% of the oxygen
reacting with the respiratory chain leads to formation of
superoxide radical. Subsequent dismutation of superoxide
anion generates H2O2, which in turn can lead to production of
OH. These oxygen radicals are normally inactivated by
endogenous scavengers mechanism present within the cell
such as antioxidant enzymes and lipid-soluble antioxidants
including vitamin E and reduced coenzyme Q. This production
of oxygen radicals can be greatly enhanced when mitochondrial
respiration is stimulated under conditions of altered redox state
and of decreased availability of ADP a condition that may occur
in ischemic/reperfused heart.
Experimental evidence has shown that during the first
minutes after cardiac post-ischemic reperfusion, a burst of ROS
generation occurs [4,5,19]. Mitochondrial ROS generation
leads to primary reaction and damage to mitochondrial
constituents including lipids and proteins in the immediate
area surrounding the locus of ROS production, given that these
species are highly reactive and short lived. Previous studies
demonstrated that reperfusion of ischemic heart is associated to
alterations of several parameters of mitochondrial bioenergetics
[14–18]. These alterations were ascribed to oxygen radicals
attack to vital mitochondrial constituents including phospho-
lipid species, specifically cardiolipin, and complexes of the
respiratory chain.
It is conceivable that oxygen radical generation and
subsequent impairment of mitochondrial function and hence
of cardiac performance may be related to pO2 during the
reoxygenation. Thus, it is possible that lowering the oxygen
tension at the beginning of the reperfusion, when a burst of
oxygen radical occurs, may reduce the generation of these
oxygen species and subsequently the mitochondrial oxidative
damage. Our results demonstrate that lowering the pO2 at the
beginning of the reperfusion (first 3 min) from 600 to 150 mm
Hg resulted in an attenuation of mitochondrial dysfunction
induced by normoxic reperfusion of the heart. In fact, we found
that hypoxic reperfusion of ischemic heart attenuated (1) the
increase in mitochondrial lipid peroxidation; (2) the decrease in
the state 3 respiration and the associated decrease in the
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complex III activities; (4) the increase in the H2O2 production;
(5) the loss in cardiolipin and the increase in its level of
peroxidation. It should be noted that the degree of protection
afforded by hypoxic reperfusion on all these bioenergetics
parameters was almost similar to the degree of protection
observed on the heart contractility (Fig. 7).
Lipid peroxidation is considered a major mechanism of
oxygen free radicals attack. This process initiates with oxygen
radical attack to double bonds of polyunsaturated fatty acids
leading to formation of conjugated dienes. Thus, the level of
conjugated dienes formation may be indicative of the level of
oxygen radical production. The fact that hypoxic reperfusion
leads to a decrease of the degree of lipid peroxidation, measured
by the level of conjugated dienes (Fig. 2), indicates that
lowering the pO2 in the beginning of the reperfusion results in a
lower production of oxygen radical species.
The results reported in Table 1 show a significantly lower
state 3 respiration rate in mitochondria isolated from normoxic
reperfused heart compared to control, while state 4 rates of
respiration were slightly decreased. This decline in state 3
respiration could be attenuated by lowering pO2 during
reperfusion. State 3 rates of respiration indicate an intact
respiratory chain and ATP synthesis. Alterations of states 3 and
4 respiration determine changes in the respiratory control ratio
(RCR). A decrease in the RCR is observed in mitochondria
isolated from normoxic reperfused rat heart compared to the
control. This decrease was attenuated when reperfusion was
carried out at low pO2. These results indicate that heart hypoxic
reperfusion had a protective effect on the integrity and on the
function of the mitochondria.
Complex I and complex III are considered the main
producers of superoxide anion in mitochondria [7–10]. The
formation of superoxide occurs via the transfer of free electrons
to molecular oxygen. This reaction occurs at specific sites of the
electron transport chain, which resides in the inner mitochon-
drial membrane. A defect in the activity of both these
respiratory complexes can be considered a potential source of
ROS production. We found that heart ischemia/reperfusion is
associated to a defect in complex I and complex III activity
which may account for the enhanced production of H2O2 in
mitochondria [16,17]. Both these effects are attenuated by
hypoxic reperfusion.
Cardiolipin is emerging as an important factor in the
regulation of mitochondrial bioenergetics in that it interacts
with several vital inner membrane proteins, including anion
carriers and respiratory chain complexes [11–13,35,36]. An
involvement of cardiolipin in the execution phase of the
apoptosis process has been also suggested [37,38]. It has also
been reported that this phospholipid is specifically required for
the electron transfer in complex I and complex III of the
mitochondrial respiratory chain [10,17,39–41]. In addition, an
involvement of cardiolipin in higher-order organization of these
components of the respiratory chain in a supercomplex in the
mitochondrial inner membrane has been proposed [42]. Thus,
changes in the mitochondrial content of cardiolipin due to
alterations of one of the enzymatic steps involved in itsbiosynthetic process [43,44] or as consequence of oxidative
damage by ROS attack may affect the activity of complex I and
complex III. As reported in Fig. 5, a marked decrease in the
cardiolipin content is observed in mitochondria isolated from
normoxic reperfused rat heart which was partially prevented by
hypoxic reperfusion. These changes in the cardiolipin content
are due to ROS-induced cardiolipin peroxidation as shown by
changes in the level of conjugated dienes (see Fig. 6). The
preservation of mitochondrial cardiolipin content results in a
reduced alteration in complex I and complex III activity and
hence, in a lower production of mitochondrial oxygen radicals.
It has been reported that the production of oxygen radicals
occurs during the early phase (first minutes) after cardiac
reperfusion (4, 5, 19). Our results are in line with these data
showing that a significant mitochondrial ROS production
occurs during the first 2 min of reperfusion, followed by a
persistently generation thereafter. This early ROS production is
markedly reduced by hypoxic condition. These data suggest that
the cardioprotective effect of hypoxia against the ischemia/
reperfusion injury can be ascribed, at least in part, to the
reduction of mitochondrial oxygen radical generation with
subsequent preservation of cardiolipin integrity, prevention of
respiratory chain complexes impairment and protection of
mitochondrial function.
Mitochondrial permeability transition pore (mPTP) is
considered an important factor in heart ischemia/reperfusion
injury and subsequently a possible target of cardioprotection
[45]. It has been reported that in isolated rat heart mPTP does
not open during the ischemic period, but does open between 2
and 5min after the onset of reperfusion [46]. Several factors may
be involved in pore opening during reperfusion such as Ca++
overload, ATP depletion, increased Pi, low lactate (higher pH
respect to ischemic condition) [46,47]. ROS generation is also
considered a key factor in pore opening, although it is still
unclear whether ROS generation is merely a consequence of
pore opening or it is an integral part of the signalling machinery
of mPTP opening. It has been reported that postconditioning
inhibits mPTP and this effect might be related to an attenuation
of oxygen-derived free radical production by the respiratory
chain in the early minutes of reflow [48]. In addition, hypoxic
postconditioning has been shown to reduce ROS production in
cardiomyocytes due to limitation of substrate oxygen [49]. In
line with these data, our results suggest a lower ROS generation
under hypoxic reperfusion as shown by the decrease in
conjugated dienes formation (an index of lipid peroxidation
due to ROS attack) and by the attenuation of the basal
production of H2O2 by complexes I and III, which are
considered the main producers of peroxide in mitochondria.
Due to the role played by ROS in mPTP opening, it is possible
that a lower ROS generation under hypoxic reperfusion may
delay or attenuate the probability of mPTP opening and this
may also contribute to limit mitochondrial dysfunction and to
prevent heart damage.
In conclusion, our results demonstrate that the restriction of
oxygen delivery to the reperfused rat heart attenuates the
alterations to mitochondrial oxidative metabolism and limits
cardiac reperfusion injury. This effect appears to be due partly to
85G. Petrosillo et al. / Biochimica et Biophysica Acta 1710 (2005) 78–86the reduction of mitochondrial oxygen radical generation during
the early phase of reperfusion. The clinical application of
oxygen radical scavengers to the treatment of the stunned
myocardium has been disappointing due to the limited ability of
most antioxidants to penetrate cell membranes. Controlling the
oxygen tension during early reperfusion may represent a
potential experimental strategy, in alternative to or in associ-
ation with antioxidants, in preventing mitochondrial dysfunc-
tion and cardiac reperfusion injury.
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